OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
61 hedge funds and large institutions have $45.4M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-7
Holders Change %
-10.29%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
11
Increased
13
Reduced
20
Closed
18
Calls
$358K
Puts
$7K
Net Calls
+$351K
Net Calls Change
-$1.89M
Top Buyers
| 1 |
HCM
Highbridge Capital Management
New York
|
+$2.68M |
| 2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$1.43M |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
+$671K |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$658K |
| 5 |
Renaissance Technologies
New York
|
+$320K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$674K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$553K |
| 3 |
Millennium Management
New York
|
-$254K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$191K |
| 5 |
VPC
Vestal Point Capital
New York
|
-$174K |
